Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI (REVERSAL-PCI)
This study has been completed.
Study NCT00715455 Information provided by Regado Biosciences, Inc.
First Received on February 14, 2008. Last Updated on May 29, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Additional conditions recognized in this trial
More general conditions related to this trial
Arterial Occlusive Diseases
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Regado Biosciences, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers